Early experiences with Curosurf therapy for severe neonatal RDS

Dévai, Gabriella; Büky, Béla

doi:10.1007/978-1-349-12553-1_20

Gabriella Dévai &
Béla Büky

17 Accesses

Abstract

Exogenous surfactant therapy is effective in both prevention and treatment of respiratory distress syndrome (RDS). The usefulness of exogenous surfactant from human or other animal sources has been confirmed in 14 randomized controlled trials from all over the world.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Reference

Collaborative European Multicenter Study Group. Surfactant replacement therapy for severe neonatal respiratory distress syndrome. Pediatrics 1988; 82: 683–91.
Google Scholar

Download references

Authors

Gabriella Dévai
View author publications
You can also search for this author in PubMed Google Scholar
Béla Büky
View author publications
You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

Second Institute of Gynaecology and Obstetrics, University of La Sapienza, Rome, Italy
E. V. Cosmi
Institute of Gynaecology and Obstetrics, University of Perugia, Policlinico Monteluce, Perugia, Italy
G. C. Di Renzo
Second Institute of Gynaecology and Obstetrics, University of La Sapienza, Rome, Italy
M. M. Anceschi

Copyright information

About this chapter

Cite this chapter

Dévai, G., Büky, B. (1991). Early experiences with Curosurf therapy for severe neonatal RDS. In: Cosmi, E.V., Di Renzo, G.C., Anceschi, M.M. (eds) The Surfactant System of the Lung. Palgrave, London. https://doi.org/10.1007/978-1-349-12553-1_20

Download citation

DOI: https://doi.org/10.1007/978-1-349-12553-1_20
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-12555-5
Online ISBN: 978-1-349-12553-1
eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics